Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Assessment of Cardiac Abnormalities in Sickle Cell Disease Patients Using Echocardiography

Osama Mukarram, MD, Gian Lima, MD, Samuel Crooks, BA, Min Jung Kim, PhD, Agnes S Kim, MD PhD

Blood (2019) 134 (Supplement_1): 4837.

https://doi.org/10.1182/blood-2019-128390

Published: 2019

Journal Articles

Inpatient Hospitalization's Associated Cost and Mortality for Myeloma Patients Undergoing Autologous Stem Cell Transplant: A 13-Year Analysis of the National Inpatient Sample

Saqib Abbasi, MD, Brian McClune, DO, Leyla Shune, MD, Suman Kambhampati, MD, Saqib Abbasi, MD

Blood (2019) 134 (Supplement_1): 3431.

https://doi.org/10.1182/blood-2019-131622

Published: 2019

Journal Articles

Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment Era

Nicholas J Boddicker, PhD, Matthew J. Maurer, MS, Melissa C Larson, MS, Cristine Allmer, BS, Susan L. Slager, PhD, Thomas M. Habermann, MD, Sunnia T Chen, BS, Hector R Villarraga, MD, Joerg Herrmann, MD, Gita Thanarajasingam, MD, Alessia Castellino, MD, Grzegorz Nowakowski, MD, David J Inwards, MD, James R. Cerhan, MD PhD, Carrie A. Thompson, MD

Blood (2019) 134 (Supplement_1): 422.

https://doi.org/10.1182/blood-2019-127203

Published: 2019

Journal Articles

Genetic Risk Factors for Cardiovascular Disease in Adult Lymphoma Patients

Sunnia T Chen, BS, Nicholas J Boddicker, PhD, Matthew J. Maurer, MS, Cristine Allmer, BS, Dennis P. Robinson, Grzegorz Nowakowski, MD, Thomas M. Habermann, MD, Susan L Slager, PhD, Carrie A. Thompson, MD, James R. Cerhan, MD PhD

Blood (2019) 134 (Supplement_1): 5215.

https://doi.org/10.1182/blood-2019-128775

Published: 2019

Journal Articles

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Gianluigi Reda, MD, Ramona Cassin, Veronica Mattiello, Tatiana Tonella, Diana Giannarelli, PhD, Bruno Fattizzo, MD, Francesco Onida, MD, Ferdinando Maria Massari, Agostino Cortelezzi, Prof

Blood (2017) 130 (Supplement 1): 1747.

https://doi.org/10.1182/blood.V130.Suppl_1.1747.1747

Published: 2017

Journal Articles

Feeding the Fire: The Comorbid and Inflammatory Backdrop of Clonal Hematopoiesis of Indeterminate Potential (CHIP) By Mutation Subtype

Elina K Cook, Terumi Izukawa, Sherylan Young, Gili Rosen, Mina Jamali, Brooke Snetsinger, Dylan Johnson, Eva Bain, Jamie Hilland, Jonah Buckstein, Janika Francis, Bushra Momtaz, Rena Buckstein, MD, Michael J. Rauh, MD PhD

Blood (2017) 130 (Supplement 1): 426.

https://doi.org/10.1182/blood.V130.Suppl_1.426.426

Published: 2017

Journal Articles

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Todd E. DeFor, MS, Chap Le, PhD, Angela R Smith, MD MS, Erica D. Warlick, MD, Nelli Bejanyan, MD, Daniel J. Weisdorf, MD

Blood (2016) 128 (22): 1167.

https://doi.org/10.1182/blood.V128.22.1167.1167

Published: 2016

Journal Articles

Early Detection of Chemotherapy- Induced Cardiotoxicity in Hematological Patients: A Prospective Study

Pilar Gómez-Prieto, MD, Teresa López, MD, Mar Moreno, Olaia Rodríguez, Elena Ramírez, Gema Casado, Antonio Buño, Jose Luis López- Sendón, MD PhD, Miguel Canales, MD PhD

Blood (2016) 128 (22): 5988.

https://doi.org/10.1182/blood.V128.22.5988.5988

Published: 2016

Journal Articles

Pomalidomide in Hereditary Hemorrhagic Telangiectasia: Interim Results of a Phase I Study

Mohamed Samour, MBBS, Caner Saygin, MD, Rashid Abdallah, RN, Suman Kundu, MS, MBA, Keith R. McCrae, MD

Blood (2016) 128 (22): 210.

https://doi.org/10.1182/blood.V128.22.210.210

Published: 2016

Journal Articles

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Amin N Alpesh, MBA, MD, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Kwanza Price, MPH, Lien Vo, MPH, PharmD, Prianka Singh, PharmD, Amanda Bruno, MPH, PhD, Jack Mardekian, PhD, Wilson Tan, MRCS, MD, Shalabh Singhal, MD, Chad Patel, PharmD, Kevin Odell, PharmD, Jeffrey Trocio, MPH

Blood (2015) 126 (23): 745.

https://doi.org/10.1182/blood.V126.23.745.745

Published: 2015

Journal Articles

Atrial Fibrillation in Patients with Chronic Lymphocytic Leukemia (CLL)

Tait D. Shanafelt, MD, Kari G. Chaffee, MS, Timothy G. Call, MD, Sameer A. Parikh, MD, Susan M. Schwager, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Asher Chanan-Khan, MD, Susan L. Slager, PhD, Neil E. Kay, MD

Blood (2015) 126 (23): 2950.

https://doi.org/10.1182/blood.V126.23.2950.2950

Published: 2015

Journal Articles

Effect Of Genotype On Pulmonary Hypertension In Patients With Thalassemia

Nattiya Teawtrakul, MD, Phuangpaka Ungprasert, MD, Burabha Pussadhamma, MD, Patcharawadee Prayalaw, Msc, Supan Fucharoen, PhD, Arunee Jetsrisuparb, MD, Saranya Pongudom, MD, Chittima Sirijerachai, MD, Kanchana Chansung, MD, Chinadol Wanitpongpun, MD, Suporn Chuncharunee, MD

Blood (2013) 122 (21): 3456.

https://doi.org/10.1182/blood.V122.21.3456.3456

Published: 2013

Journal Articles

Acquired Von Willebrand Disease – To Treat Or Not To Treat The Inhibitor?

Surbhi Shah, MBBS, Mark Reding

Blood (2013) 122 (21): 4744.

https://doi.org/10.1182/blood.V122.21.4744.4744

Published: 2013

Journal Articles

Laboratory Predictors Of Loss Of High Molecular Weight Multimers In Patients With Cardiovascular Disease-Associated Acquired Von Willebrand Syndrom

Ewa M. Wysokinska, MD, Dong Chen, M.D., Ph.D., Joseph L Blackshear, MD

Blood (2013) 122 (21): 335.

https://doi.org/10.1182/blood.V122.21.335.335

Published: 2013

Journal Articles

Host Genetics and Risk of Cardiovascular Disease in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Carrie A. Thompson, MD, Thomas M Habermann, MD, Matthew J Maurer, MS, Cristine Allmer, BS, Susan L Slager, PhD, James R Cerhan, MD, PhD

Blood (2012) 120 (21): 1573.

https://doi.org/10.1182/blood.V120.21.1573.1573

Published: 2012

Journal Articles

Prediction of Non-Relapse Mortality in Recipients of Reduced Intensity Conditioning Allo-HSCT with Acute Myeloid Leukemia in First Complete Remission: Integrating the Seattle Comorbidity Index (HCT-CI) and EBMT Scoring Systems

Jurjen Versluis, MD, Myriam Labopin, PhD, Dietger Niederwieser, Gérard Socié, MD PhD, Richard F Schlenk, MD, Noel Milpied, MD, Arnon Nagler, MD, Didier Blaise, MD, Vanderson Rocha, MD PhD, Jan Cornelissen, MD PhD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 734.

https://doi.org/10.1182/blood.V120.21.734.734

Published: 2012

Journal Articles

Hospital Demand for Blood Components in Ontario Correlates with Selected Diagnostic and Procedural Activities

Jacob M Pendergrast, MD, FRCP(C), Brandon Zagorski, MS

Blood (2012) 120 (21): 4272.

https://doi.org/10.1182/blood.V120.21.4272.4272

Published: 2012

Journal Articles

The Impact of Comorbidity in Myelodysplastic Syndromes

Yu-Chung Huang, MD, Kuo-Wei Chen, MD, Ying-Chung Hong, MD, Chia-Jen Liu, MD, Yuan-Bin Yu, MD, Cheng-Hwai Tzeng, MD

Blood (2012) 120 (21): 4940.

https://doi.org/10.1182/blood.V120.21.4940.4940

Published: 2012

Journal Articles

Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) to Predict Non Relapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Marcos Paulo Colella, MD, Eliana C M Miranda, Francisco J. P Aranha, Md, Virginio C.A Fernandes-Junior, Md, Samuel de Souza Medina, MD, Carmino De Souza, MD, PhD, Afonso Celso Vigorito, MD, PhD

Blood (2011) 118 (21): 4561.

https://doi.org/10.1182/blood.V118.21.4561.4561

Published: 2011

Journal Articles

Cardiac Outcomes in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Carrie A. Thompson, MD, Hongxiu Luo, Matthew J Maurer, MS, Cristine Allmer, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, David James Inwards, MD, Patrick B. Johnston, Luis F. Porrata, MD, Thomas E. Witzig, MD, Veronique Roger, MD, James R Cerhan, MD, PhD

Blood (2011) 118 (21): 2656.

https://doi.org/10.1182/blood.V118.21.2656.2656

Published: 2011

NARROW

Assessment of Cardiac Abnormalities in Sickle Cell Disease Patients Using Echocardiography

Inpatient Hospitalization's Associated Cost and Mortality for Myeloma Patients Undergoing Autologous Stem Cell Transplant: A 13-Year Analysis of the National Inpatient Sample

Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment Era

Genetic Risk Factors for Cardiovascular Disease in Adult Lymphoma Patients

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Feeding the Fire: The Comorbid and Inflammatory Backdrop of Clonal Hematopoiesis of Indeterminate Potential (CHIP) By Mutation Subtype

Validation of a Modified Comorbidity Index for Allogeneic Hematopoietic Cell Transplant

Early Detection of Chemotherapy- Induced Cardiotoxicity in Hematological Patients: A Prospective Study

Pomalidomide in Hereditary Hemorrhagic Telangiectasia: Interim Results of a Phase I Study

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Atrial Fibrillation in Patients with Chronic Lymphocytic Leukemia (CLL)

Effect Of Genotype On Pulmonary Hypertension In Patients With Thalassemia

Acquired Von Willebrand Disease – To Treat Or Not To Treat The Inhibitor?

Laboratory Predictors Of Loss Of High Molecular Weight Multimers In Patients With Cardiovascular Disease-Associated Acquired Von Willebrand Syndrom

Host Genetics and Risk of Cardiovascular Disease in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Prediction of Non-Relapse Mortality in Recipients of Reduced Intensity Conditioning Allo-HSCT with Acute Myeloid Leukemia in First Complete Remission: Integrating the Seattle Comorbidity Index (HCT-CI) and EBMT Scoring Systems

Hospital Demand for Blood Components in Ontario Correlates with Selected Diagnostic and Procedural Activities

The Impact of Comorbidity in Myelodysplastic Syndromes

Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) to Predict Non Relapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Cardiac Outcomes in a Prospective Cohort of Adult Non-Hodgkin Lymphoma Survivors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only